Has Kasra Rowshan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $151,585 in general payments to Kasra Rowshan, MD across 81 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kasra Rowshan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kasra Rowshan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kasra Rowshan, MD

Orthopaedic Surgery · Newport Beach, CANPI 1942463112

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $149,764 of the $151,585 with a category attached, or 98.8%. Spineart SA accounts for 98.8% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $37,592, 4.2 times the $8,882 reported in 2019. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$151,585in general payments, 2019–2025

Across 81 payments — averaging $1871.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Spineart SA$150K
Saluda Medical Americas, Inc.$445
Abbott$205
Boston Scientific$202
Nevro Corp.$184
Stryker$146
plus $639 from 17 others

What the payments were for

Royalty or licence$149,76499%
Food & beverage$1,8211%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Spineart SA	14	$149,764
Saluda Medical Americas, Inc.	12	$445
Abbott	14	$205
Boston Scientific	5	$202
Nevro Corp.	8	$184
Stryker	3	$146
Providence Medical Technology, Inc.	1	$84
Radius Health, Inc.	3	$79
Johnson & Johnson	4	$70
Electronic Waveform Lab, Inc.	1	$53
Aegis Spine, Inc.	1	$45
Baxter Healthcare	1	$44
Bioventus LLC	2	$42
Pacira Therapeutics, Inc.	1	$37
Si-bone, Inc.	2	$35
Zimmer Biomet	1	$33
Vertos Medical, Inc.	1	$23
Nalu Medical, Inc.	2	$18
Globus Medical	1	$18
Endo Pharmaceuticals Inc.	1	$16
Stimwave Technologies Incorporated	1	$16
Arteriocyte Medical Systems, Inc.	1	$14
Spineology Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$151,585 in reported general payments places this provider in the 90th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024

$49,780

Medicare patients

Services billed

782

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pregabalin	18	$410
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	30	$364
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	25	$253
Tramadol Hcl	24	$204
Gabapentin	35	$190
Meloxicam	46	$161
Methocarbamol	12	$97
Zolpidem Tartrate	12	$32
Ibuprofen	15	$18

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Newport Beach

Hafiz KassamNewport Beach$914K
Bradford HackArcadia$18.3M
Robert GorabOrange$13.6M
Kelly VinceLos Angeles$9.6M
Stephen HowellSacramento$9.4M
Thomas CoonRed Bluff$9.2M
Nirav AminPlacentia$5.6M
Tom NorrisSan Francisco$5.3M
Jay LiebermanLos Angeles$4.8M
Peter NewtonSan Diego$4.2M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →